17.11.2023 | Published by Endpoints News

bit.bio cell therapy pipeline featured in Endpoints News

Featured Image

Ahead of the announcement of our cell therapy pipeline and lead candidate, bit.bio CEO Mark Kotter spoke with Endpoints News.

The piece covers our lead cell therapy candidate for acute liver failure - bbHEP01 - and the wider cell therapy pipeline that was announced on 8 November. They also cover opti-ox™ and the overall cell programming approach that we are taking to produce human cells that are consistent at scale for therapies. 

Read the full article in Endpoints News

Related pages

About us Coding cells to advance the wellbeing of humanity
Careers See the latest openings
Blog See the latest blogs